Rash Scan

Rash Scan is a revenue-stage iOS health app (founded 2025-09-09) that bundles a rash scanner, cosmetic scanner, and medication reminders. Its unit economics look strong on the surface: the app reported $560 last month, $595 in recurring revenue, and a very healthy profit margin of 90%, which is typical of low-overhead digital products. The main warning flag is the recent -1% decline in growth — at this revenue scale that kind of dip can materially change runway or valuation. The business is small in absolute revenue and listed for sale, so the realistic path to value likely requires either improving acquisition/retention or folding the product into a larger health portfolio. For anyone evaluating it, dig into retention, acquisition channels, and any clinical/regulatory claims tied to the scanner features.

◆ Best suited for

A judgment from project data — not a user review.